Ticker
SPROCompany Name
SPERO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Income Common Stock | Net Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -53.6M | -110.34% | $ 48.58M |
3/31/2025 | $ -69.76M | -156.48% | $ 44.58M |
12/31/2024 | $ -68.57M | -142.91% | $ 47.98M |
9/30/2024 | $ 3.51M | 3.3% | $ 106.45M |
6/30/2024 | $ 17.45M | 14.74% | $ 118.46M |
3/31/2024 | $ 23.4M | 21.09% | $ 110.98M |
12/31/2023 | $ 22.81M | 21.98% | $ 103.78M |
9/30/2023 | $ -1.61M | -2.08% | $ 77.7M |
6/30/2023 | $ -10.08M | -18.59% | $ 54.23M |
3/31/2023 | $ -26.85M | -50.18% | $ 53.51M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Revenues
(=) Net %
Net % for SPERO THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -84.68M ] / Revenues [ $ 11.05M ]
(=) Net % [ -766.14% ]
Minimum
Sep 30, 2022
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.2K |
---|---|
min | -64.23% |
max | 69.74% |
average | 4.77% |
median | 5.24% |
std | 19.84% |